Q1 2024 EPS Estimates for Danaher Co. Decreased by Analyst (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Investment analysts at Zacks Research decreased their Q1 2024 earnings estimates for Danaher in a research note issued to investors on Wednesday, April 17th. Zacks Research analyst R. Department now forecasts that the conglomerate will earn $1.72 per share for the quarter, down from their previous forecast of $1.74. The consensus estimate for Danaher’s current full-year earnings is $7.62 per share. Zacks Research also issued estimates for Danaher’s Q2 2024 earnings at $1.62 EPS, Q3 2024 earnings at $1.90 EPS, Q4 2024 earnings at $2.34 EPS, Q3 2025 earnings at $2.14 EPS, Q4 2025 earnings at $2.42 EPS, FY2025 earnings at $8.47 EPS, Q1 2026 earnings at $2.25 EPS and FY2026 earnings at $10.01 EPS.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.18. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The business had revenue of $6.41 billion during the quarter, compared to the consensus estimate of $6.10 billion. During the same quarter in the prior year, the firm earned $2.87 earnings per share. The business’s quarterly revenue was down 10.2% compared to the same quarter last year.

Several other research firms have also recently issued reports on DHR. Barclays increased their price target on shares of Danaher from $240.00 to $260.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 10th. Raymond James increased their price target on shares of Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and increased their price target for the stock from $250.00 to $280.00 in a report on Wednesday. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Finally, Citigroup increased their price target on shares of Danaher from $255.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Six analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $268.27.

Danaher Price Performance

Shares of DHR opened at $236.37 on Thursday. Danaher has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The company has a market capitalization of $175.04 billion, a price-to-earnings ratio of 36.99, a price-to-earnings-growth ratio of 3.65 and a beta of 0.83. The firm has a 50-day simple moving average of $249.09 and a 200-day simple moving average of $229.90. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68.

Institutional Trading of Danaher

A number of hedge funds have recently bought and sold shares of DHR. Wellington Management Group LLP boosted its holdings in shares of Danaher by 12.0% in the 4th quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock valued at $6,460,966,000 after purchasing an additional 2,998,161 shares during the last quarter. Moneta Group Investment Advisors LLC boosted its holdings in shares of Danaher by 96,490.5% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after purchasing an additional 23,262,904 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Danaher by 10.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,757,558 shares of the conglomerate’s stock valued at $3,876,694,000 after purchasing an additional 1,619,586 shares during the last quarter. Capital International Investors boosted its holdings in shares of Danaher by 9.1% in the 4th quarter. Capital International Investors now owns 15,956,519 shares of the conglomerate’s stock valued at $3,691,735,000 after purchasing an additional 1,334,781 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Danaher by 6.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock valued at $2,030,327,000 after purchasing an additional 502,868 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, Director Teri List sold 3,289 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Daniel Raskas sold 23,757 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the sale, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teri List sold 3,289 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the sale, the director now owns 19,726 shares in the company, valued at approximately $4,898,360.32. The disclosure for this sale can be found here. Insiders sold a total of 32,957 shares of company stock valued at $8,265,802 in the last ninety days. Corporate insiders own 11.10% of the company’s stock.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. This is a boost from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is 16.90%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.